Production of an (A)H1N1 flu vaccine will begin today and the vaccine will hit the market by mid-November if clinical trials and the certification process go as planned, state-sponsored Adimmune Corp said yesterday.
Adimmune, otherwise known as Kuo-kwang Biotechnology Co, won a bid tendered by the Centers for Disease Control (CDC) last month to produce 5 million doses of (A)H1N1 vaccine at NT$199 each.
Adimmune deputy chief executive officer and president Ignatius Wei (魏逸之) told reporters yesterday that the company would begin injecting chicken embryos with a strain of the type A flu virus created by New York Medical College, the first step toward mass production of type A (H1N1) vaccines.
Once mass production is underway, clinical trials can begin, Wei said
The trials will be conducted by Huang Li-min (黃立民), a professor at National Taiwan University Hospital and chief of the infectious diseases division in the pediatric department.
“We will conduct clinical trial with 200 adults — half of which will be under 60 years old, and half above,” Huang said.
Following the dosage used in seasonal flu vaccines, half of the tested shots will be 15mg and the other half will be 30mg, he said.
“We are quite certain that one of them, or both, will work,” he said.
As the principle investigator of the clinical trials he needs to maintain a neutral position in terms of the drug candidates, Huang said.
“I really hope it works ... Of course, the hospital will not be working on a vaccine that we think will not work,” he said.
Given that the world’s vaccine production capacity is 900 million doses annually, it would be difficult for everyone on earth — about 6 billion people — to be vaccinated, he said.
The bad news is that swine flu is already beginning to spread, Huang said, adding that he has seen many people in his outpatient practice with the virus.
Contrary to predictions that swine flu will not begin to spread widely until the weather cools down in the fall, Huang said: “When a virus is strong enough, it will spread regardless of the temperature.”
Depending on foreign companies for type A flu vaccines would be a long shot, so Taiwan must produce its own vaccines, he said.
Given the skepticism over Adimmune’s decision to begin mass production of its vaccine even before the clinical trials are complete, Wei said: “Mass production must begin as soon as possible. Time is not on our side.”
A 200-person trial is already a larger test than what the WHO deems necessary, because the WHO considers the type A flu a common flu virus, therefore tests for its vaccine do not need to follow procedures for brand new drugs, he said.
A decision to describe a Chinese Ministry of Foreign Affairs statement on Singapore’s Taiwan policy as “erroneous” was made because the city-state has its own “one China policy” and has not followed Beijing’s “one China principle,” Deputy Minister of Foreign Affairs Tien Chung-kwang (田中光) said yesterday. It has been a longstanding practice for the People’s Republic of China (PRC) to speak on other countries’ behalf concerning Taiwan, Tien said. The latest example was a statement issued by the PRC after a meeting between Singaporean Prime Minister Lawrence Wong (黃循財) and Chinese President Xi Jinping (習近平) on the sidelines of the APEC summit
Taiwan’s passport ranked 34th in the world, with access to 141 visa-free destinations, according to the latest update to the Henley Passport Index released today. The index put together by Henley & Partners ranks 199 passports globally based on the number of destinations holders can access without a visa out of 227, and is updated monthly. The 141 visa-free destinations for Taiwanese passport holders are a slight decrease from last year, when holders had access to 145 destinations. Botswana and Columbia are among the countries that have recently ended visa-free status for Taiwanese after “bowing to pressure from the Chinese government,” the Ministry
‘SIGN OF DANGER’: Beijing has never directly named Taiwanese leaders before, so China is saying that its actions are aimed at the DPP, a foundation official said National Security Bureau (NSB) Director-General Tsai Ming-yen (蔡明彥) yesterday accused Beijing of spreading propaganda, saying that Chinese President Xi Jinping (習近平) had singled out President William Lai (賴清德) in his meeting with US President Joe Biden when talking about those whose “true nature” seek Taiwanese independence. The Biden-Xi meeting took place on the sidelines of the APEC summit in Peru on Saturday. “If the US cares about maintaining peace across the Taiwan Strait, it is crucial that it sees clearly the true nature of Lai and the ruling Democratic Progressive Party (DPP) in seeking Taiwanese independence, handles the Taiwan question with extra
HEALTHCARE: Following a 2022 Constitutional Court ruling, Taiwanese traveling overseas for six months would no longer be able to suspend their insurance Measures allowing people to suspend National Health Insurance (NHI) services if they plan to leave the country for six months would be abolished starting Dec. 23, NHIA Director-General Shih Chung-liang (石崇良) said yesterday. The decision followed the Constitutional Court’s ruling in 2022 that the regulation was unconstitutional and that it would invalidate the regulation automatically unless the NHIA amended it to conform with the Constitution. The agency would amend the regulations to remove the articles and sections that allow the suspension of NHI services, and also introduce provisional clauses for those who suspended their NHI services before Dec. 23, Shih said. According to
RSS